NTC Ophthalmics Iberica

NTC Ophthalmics Iberica is the Spanish subsidiary of NTC Srl, an Italian pharmaceutical company specializing in the development and commercialization of innovative ophthalmic products. The company focuses on therapeutic areas including dry eye, blepharitis, and ocular infections, as well as post-surgical inflammation management. Their flagship product, Ducressa, is a fixed-dose combination of levofloxacin and dexamethasone designed to prevent infection and reduce inflammation following cataract surgery. NTC Ophthalmics Iberica operates with a commitment to evidence-based medicine, leveraging a robust R&D pipeline to provide high-quality eye care solutions across the Iberian market.